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Abstract
Throughout the day, clock proteins synchronize changes in animal physiology (e.g., wakefulness and appetite) with external
cues (e.g., daylight and food). In vertebrates, both casein kinase 1 delta and epsilon (CK1d and CK1e) regulate these
circadian changes by phosphorylating other core clock proteins. In addition, CK1 can regulate circadian-dependent
transcription in a non-catalytic manner, however, the mechanism is unknown. Furthermore, the extent of functional
redundancy between these closely related kinases is debated. To further advance knowledge about CK1d and CK1e
mechanisms of action in the biological clock, we first carried out proteomic analysis of both kinases in human cells. Next, we
tested interesting candidates in a cell-based circadian readout which resulted in the discovery of PROHIBITIN 2 (PHB2) as a
modulator of period length. Decreasing the expression of PHB2 increases circadian-driven transcription, thus revealing PHB2
acts as an inhibitor in the molecular clock. While stable binding of PHB2 to either kinase was not detected, knocking down
CK1e expression increases PHB2 protein levels and, unexpectedly, knocking down CK1d decreases PHB2 transcript levels.
Thus, isolating CK1 protein complexes led to the identification of PHB2 as an inhibitor of circadian transcription.
Furthermore, we show that CK1d and CK1e differentially regulate the expression of PHB2.
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Introduction
All vertebrates have orthologues for casein kinase 1 isoforms,
delta and epsilon (CK1d and CK1e), which play prominent roles
in diverse cellular processes such as proliferation, growth, and
survival [1]. CK1d/e regulate daily biological rhythms as part of
the core molecular clock [2]. In humans, point mutations in both
CK1d (NP_001884) and its substrate, PERIOD 2 (PER2
(NP_073728)), have been shown to cause familial advanced sleep
phase syndrome [3,4]. PER2 is a prominent protein component of
the negative feedback loop necessary for the daily cycling of gene
transcripts [2]. PERs and CRYPTOCHROMES (CRYs) inhibit
BMAL (NP_001001463) and CLOCK (NP_004889) driven
transcription of genes that contain E-box response elements,
including PER and CRY. Systematic control of transcription,
translation and post-translation modifications is essential to
efficiently regulate physiological changes (e.g. body temperature
and metabolism) that occur throughout the day.
In addition to enzymatic regulation of core clock proteins,
recent work suggests that CK1 acts in a non-catalytic manner to
regulate circadian rhythms [5]. We carried out proteomic analysis
of CK1d and e to gain a better understanding of how they function
in the molecular clock. Considering the inherent temporal nature
of circadian biology, we isolated CK1 protein complexes in
synchronized cells and tested interesting candidates in a circadian
cell-based assay using dexamethasone, a synthetic glucocorticoid,
to reset the molecular clock in peripheral cells [6].
Results and Discussion
The purpose of this study was to use CK1d/e proteomics to
gain mechanistic insights into the molecular clock. TAPTag has
been successfully used to study basal protein-protein interactions in
various cell types by stably over-expressing low amounts of dually-
tagged bait proteins [7]. We chose to isolate dexamethasone-
dependent CK1 protein complexes over time due to the inherent
temporal nature of circadian rhythms (Fig. 1A). Upon establishing
that circadian gene oscillation occurs in HEK293 (HEK) cells
synchronized with dexamethasone (Fig. S1A), we made HEK
CK1d- and e-stable cell lines. To capture whole protein complexes
including proteins bound to the kinases (directly (orthosterically
and allosterically), indirectly, stably, and transiently), intact cells
were treated with a cell-permeable thio-cleavable crosslinker,
dithiobis[succinimidyl propionate] (DSP). DSP, a homobifunc-
tional crosslinker, reacts with primary amines that are at most
12.0 A ˚ apart [8]. Intracellular crosslinking maintains protein
subcellular localization and increases retention of proteins that
would otherwise be lost in the process of purification. To
determine crosslinking efficacy, CK1e (NP_001885) stable cells
were treated with dexamethasone, harvested 12 h (hour) later,
divided in half and treated with vehicle (DMSO) or DSP.
Following tandem purification, 10% of the final elution was
analyzed by Western blot (Fig. 1B). In non-reducing conditions,
DSP-treated cells produced higher molecular weight bands
containing CK1e that were not detected in eluate from cells
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e31987treated with vehicle (Fig. 1B, left). This result suggested that the
crosslinker was working as expected to stabilize larger CK1e
protein complexes. Next, we investigated the effect of dexameth-
asone on these DSP-stabilized protein complexes immediately, 1 h
and 24 h after dexamethasone exposure. As shown in Fig. 1B
(right) under non-reducing conditions, there was no observable
difference in the intensity of higher molecular weight bands from
eluates of cells treated with vehicle or dexamethasone immediately
Figure 1. Time-dependent CK1d and CK1e proteomics. (A) Illustration of screen. Cells stably expressing dually-tagged (yellow hexagon) CK1
were treated with dexamethasone (DEX) and harvested at different time points. Protein complexes were stabilized with DSP prior to lysis and
purification for peptide identification by LC-MS/MS. (B) HA immunoblot showing DSP efficacy and the effect of dexamethasone on CK1e complexes.
(C) Diagram showing proteins pulled out at the different time points by CK1d and CK1e. Numbers represent hours after DEX that cells were
harvested. Open circles were pulled out with both CK1d and CK1e (orange circles are known circadian proteins). Closed circles were pulled out with
CK1d alone (black-fill) or CK1e alone (red-fill).
doi:10.1371/journal.pone.0031987.g001
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observed an increase in CK1e protein complexes. 24 h later,
CK1e expression is reduced, suggesting a decrease in the cell
viability under these conditions. When we treated final eluates
with the reducing agent DTT, we observed a single band of the
expected size of tagged CK1e in all conditions. Together, these
results suggested that we could induce, stabilize and isolate
dexamethasone-induced CK1 protein complexes. Thus, DSP-
stabilized protein complexes were isolated using tandem affinity
tagging (TAPTag) purification at time points between 1 and
12 hours followed by protein identification using tandem mass
spectrometry (LC-MS/MS).
Following the protocol outlined above, peptides identified by
LC-MS/MS (Fig. 1C (see Table S1 for complete list)) suggested
that while there was considerable overlap in the proteins bound by
CK1d and CK1e, there were also some differences. First, the
similarities: we identified known core clock proteins, PER1
(NP_002607), PER2 and CRYPTOCHROME 1 (CRY1
(NP_004066)) and a PER1-associated protein, NON POU
DOMAIN CONTAINING OCTAMER BINDING PROTEIN
(NONO (NP_001138880)) [9]. Additionally, proto-oncogene P53
(TP53 (NP_000537)), a known substrate, and phospho-serine/
threonine signaling molecules 14-3-3 proteins (YWHA
(NP_003395)), were pulled out by both kinases. These results
substantiated our method. With regard to differences in binding,
we consistently pulled out two poorly studied proteins with CK1d
but not CK1e, GAPVD1 (GTPASE-ACTIVATING PROTEIN
AND VP59 CONTAINING PROTEIN 1 (NP_079985)) and
FAM83H (NP_940890). While further analysis is needed to
confirm the binding specificity of these proteins, our results further
support the hypothesis that CK1d and CK1e do not act
completely redundantly.
Upon pulling out known substrates, we next tested for novel
CK1d/e binding partners and/or substrates using cell-based co-
purification and kinase assays. Tagged-hits were transiently
transfected either alone or with CK1d or e, after which the cells
were incubated with radio-labeled sodium orthophosphate (P
32)t o
detect phosphorylation. The overexpressed protein hits were
purified and analyzed by Western Blot analysis. One of the eight
proteins tested, CXORF39 (NP_997201), co-purified with both
kinases (Fig. 2A). Furthermore, cotransfection of CXORF39 with
GFP-CK1d or GFP-CK1e slowed its mobility (HA) and increased
its P
32 incorporation. This result suggests that CXORF39, a
protein of unknown function, may be a novel CK1 substrate and
binding partner. In contrast to the change in phosphorylation of
CXORF39, we detected weaker changes in the phospho-state of
SERINE/THREONINE-PROTEIN PHOSPHATASE 6 REG-
ULATORY SUBUNIT 3 (SAPS3 (NP_997201)). Using densi-
tometry to quantify SAPS3 P
32 and HA bands, we determined the
ratio of P
32 to HA (Fig. 2A, graph inset) and detected a small
increase with CK1d, and interestingly, a decrease with CK1e,i n
P
32 incorporation. These results provide interesting leads for two
proteins whose phospho-state was altered by increasing the
expression levels of CK1d and CK1e. Further experiments
including in vitro kinase assays with purified proteins and
identification of the relevant sites of phosphorylation will be
necessary to determine whether CXORF39 and SAPS3 are direct
CK1 substrates.
Since the purpose of this study was to explore the molecular
mechanisms underlying CK1d and CK1e clock function, we
performed Lumicycle assays to test candidate proteins from
proteomic results. In this circadian assay, U2OS cells that are
stably expressing luciferase driven by the BMAL1 promoter can be
monitored over several days [10]. BMAL1 is a transcription factor
that drives, and is regulated, in a circadian manner. Cells were
transfected with siRNA of candidate genes, synchronized with
dexamethasone, and cyclical bioluminescence was measured. We
selected candidates to target with siRNA based on their potential
roles in cell signaling. As shown in Figure 2B, knock-down of
PHB2 led to the most robust change (lengthening) of the period
length. A second siRNA targeting PHB2 also lengthened the
period of reporter oscillation. Of the 3 siRNAs targeting
PROHIBITIN (PHB1 (NP_002625)), a closely related protein
that has been shown to heterodimerize with PHB2 (Fig. S1B and
[11]), only one (PHB1.2) had an effect (Fig. 2C, right). Knock-
down efficacy of the prohibitin siRNAs was confirmed using over-
expressed proteins (Fig. S1C). While the other 2 PHB1 siRNAs
(PHB1.1 and PHB1.3) both effectively knocked down PHB1
protein levels, they did not affect period length. We thus interpret
the PHB1.2 siRNA result as a non-specific effect. Both PHB1 and
PHB2 have previously been shown to regulate mitochondrial
function and estrogen signaling [11]. Our findings suggest that
specifically targeting PHB2 and not a closely related protein,
PHB1, perturbs the normal regulation of circadian rhythmicity.
Similar results were obtained when Drosophila adult locomotor
activity was monitored following RNAi-facilitated knock-down of
PHB1 and 2 (Table S2, Fig. S2 and S3). Additionally, we
measured transcript levels of both dprohibitins in wild-type fly heads
under constant darkness every 2 h for 48 h and found that they
were not regulated in a circadian manner (Fig. S2A). This is
consistent with previous results from mouse studies that are
cataloged in the BIOGPS circadian database (http://biogps.org/
circadian/#goto=genereport&id=11331).
To gain mechanistic insights into whether PHB2 regulates
circadian gene expression, we carried out luciferase assays using
the M34-luc reporter that contains multiple E-boxes upstream of
luciferase [12]. BMAL1 and CLOCK bind to E-boxes in the
promoters of clock controlled genes thus activating their
transcription [2]. PHB2 loss-of-function (LOF) via siRNA, in the
absence or presence of BMAL1/CLOCK, resulted in a significant
increase in reporter activity compared to control (Fig. 3A). CK1d
LOF also potentiated reporter activity both in the absence and
presence of over-expressed BMAL1/CLOCK. Conversely, CK1e
LOF significantly reduced BMAL1/CLOCK-activation of the
reporter (p,0.05). Considering this result, we measured endoge-
nous PER2 mRNA by RT-qPCR following the knockdown of
PHB2, CK1d and CK1e. PER2 is a prominent protein component
of the negative feedback loop in the clock that oscillates in a
circadian manner [2]. As predicted, decreasing PHB2 expression
resulted in an increase in PER2 mRNA (Fig. 3B). We also observed
the expected PHB2 and PER2 siRNA-facilitated decrease in their
respective transcripts compared to control. Surprisingly, knocking
down CK1d led to a decrease in PHB2, suggesting that CK1d plays
a role in regulating PHB2 transcription. Taken together, these
results make a strong case for PHB2 acting as a repressor of E-box
dependent transcription.
Lastly, we investigated whether CK1d and CK1e regulate the
expression of endogenous PHB2 protein. Monitoring PHB2
relative to ACTIN (Fig. 3C) showed that CK1d LOF had a
variable effect while reducing CK1e expression consistently
resulted in an increase on PHB2 protein expression without
altering PHB2 mRNA levels (Fig. 3B). Notably, we initially pulled
out PHB2 with CK1e 1 h after dexamethasone treatment (Fig. 1C).
Considering we cannot detect basal binding or a change in PHB2
phosphorylation state following the overexpression of CK1e
(Fig. 2A), it is likely that the effect of CK1e on PHB2 protein
may be indirect, requiring other protein(s). Thus, while PHB2
transcription is controlled by CK1d, its protein levels are regulated
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down the expression of CK1d and CK1e (http://biogps.org/
circadian/#goto=genereport&id=1454) led to lengthening of the
circadian period in U2OS cells. Interestingly, we found that
knocking down the expression of PHB2 also led to lengthening of
the circadian period. Given our results showing PHB2 is regulated
by CKId and CKIe at both mRNA and protein levels, it is possible
that PHB2 acts, at least in part, as a downstream executor for the
effects of CK1d and/or CK1e on circadian period.
In this study we have shown that PHB2 is new regulatory
protein in the molecular clock. We discovered PHB2 using
proteomics in search of potential substrates and binding partners
of CK1d and CK1e (Fig. 1). Due to our specific interest in the
circadian role of both kinases, we then narrowed our search using
Figure 2. Cell-based kinase and Lumicycle assays. (A) Autoradiography (P
32) and immunoblots of HA-tagged proteins (green) and GFP-tagged
CK1d or CK1e (red). Graph inset showing percent change of SAPS3 phosphorylation by CK1d and CK1e (n=2). (B) Results from LumiCycle assays in
cells transfected with indicated siRNAs. (C) Representative traces after cell synchronization of control (gray), CRY2 (green) and PHB2 (white) siRNAs
(left). Graph showing effects of control siRNA, CRY2 siRNA, two PHB2 siRNAs (PHB2.1 & PHB2.2) and three PHB1 siRNAs (PHB1.1, PHB1.2, PHB1.3) (right).
(Sample size indicated by number inside each bar, ** indicates p,0.001 following regression analysis. Error bars indicate SEM).
doi:10.1371/journal.pone.0031987.g002
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proteins were involved in circadian biology. As a result, we
identified PHB2 as a regulator of circadian rhythms (Fig. 2C and
S3). We show that the mechanism by which PHB2 carries out its
function is by inhibiting circadian-driven transcription. Finally we
found that CK1d promotes PHB2 transcription, whereas CK1e
reduces its protein expression (Fig. 3). However, we were unable to
detect PHB2 bound to (or phosphorylated by) either kinase under
basal conditions (Fig. 2A), indicating that CK1 regulates PHB2
indirectly.
Our study extends previous studies regarding PHB2 functioning
independently from PHB1, an interaction that is crucial for the
maintenance of mitochondrial morphology [11]. We show that
reducing the expression of PHB2, but not PHB1, affects circadian
rhythmicity in cells (Fig. 2C). PHB2 (but not PHB1) has been
shown to translocate from the mitochondria to the nucleus in cells
following treatment with estrogen to regulate gene transcription
[13]. Additionally, another protein (BIG3/WRD5) has been
shown to bind to and prevent translocation of PHB2 to the
nucleus when overexpressed [14]. Interestingly, WRD5 is a PER1-
associated protein that indirectly regulates circadian gene
transcription [9] providing another clue on how PHB2 may
function. Future molecular studies and functional assays examin-
ing whether CK1d, CK1e, PHB2 and WRD5 act together to
regulate circadian biology are necessary.
In summary, we have shown that PHB2 is novel regulatory
protein in the molecular clock by isolating CK1d and CK1e
protein complexes. Studies involving kinases often focus on
identifying protein substrates [15]. While kinase-substrate interac-
tions mechanistically explain several kinase-dependent cellular
outcomes, kinase function relies on constantly changing auxiliary
protein-protein interactions. The major strength of this study is
that we examined whole protein complexes in a context-
dependent manner. Dynamic proteomics coupled with relevant
molecular readouts will advance knowledge not only about normal
protein function but can also provide drug targets for relevant
human disease states. This feasible approach is especially relevant
when elucidating how single proteins such as CK1d and CK1e
carry out their pleiotropic roles.
Materials and Methods
Plasmids and antibodies
PGLUE vector was used to clone TAPTAG constructs that
were used for proteomics and kinase assays. GFP constructs were
made in a pCDNA3 vector background. A rat HA antibody (3F10)
was used to blot for HA in the pGLUE constructs. Rabbit anti-
human PHB2 antibody was obtained from Santa Cruz (sc-67045).
Mouse anti-ACTIN antibody was obtained from Sigma (A5316).
Secondary antibodies were obtained from LICOR Biosciences.
TAP-Tag with DSP and dexamethasone
Human embryonic kidney cells (293) were obtained from the
UCSF Cell Culture Facility (Mission Bay) and stable cell-lines
were generated as previously described [7]. The purification tags
used in this case were streptavidin and calmodulin binding protein.
Figure 3. PHB2 is molecular clock component. (A) Representative graph (n=3) of M34-luciferase reporter assays following transient
cotransfections of M34-luc, renilla, GFP and indicated siRNAs without (left) or with (right) BMAL1 and CLOCK.( B) Representative graph (n=3) showing
transcript levels of PER2 and PHB2 24 h after transfecting cells with control, PHB2, CK1d, CK1e and PER2 siRNA. (C) Graph (n=3) showing the effect of
indicated siRNAs without (left, marked as control) or with (right, marked as PHB2) PHB2 siRNA on PHB2 protein levels relative to ACTIN. (D) Illustration
summarizing molecular mechanism based on our results where shapes indicate proteins. (* indicates p,0.05; ** indicates p,0.01; determined by
student t-test analysis. Error bars indicate STDEV).
doi:10.1371/journal.pone.0031987.g003
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protein expression. Prior to tandem affinity purification, 15 15 cm
plates with stable cells at 75–90% confluency were treated for
15 min with 100 nm dexamethasone. For crosslinking, cells were
harvested at the appropriate duration and were resuspended in
30 ml of 1.5 mM fresh DSP in PBS (DSP was obtained from
Pierce cat. no. 22586). Incubation on ice for 2 hours, with gentle
swirling from time to time followed. Tris (pH 7.5 or 8) to a final
concentration of 50 mM was added, and cells were incubated on
ice for 30 minutes. Cells were pelleted, and washed 2 times with
ice-cold PBS to get rid of excess reagent. Lysis and purification of
complexes proceeded as described in [7]. To reverse crosslinker,
final eluates were reduced in 20 microliters of 50 mM (final) DTT
in 50 mM ammonium bicarbonate for 75 minutes at 37uC prior
to trypsinization for MS/MS analysis.
Tandem Mass Spectrometry
TAP-Tagged proteins were eluted and subjected to reduction
with DTT and alkylation with iodoacetamide in-gel digestion with
trypsin overnight at pH 8.3. Reversed-phase microcapillary liquid
chromatography tandem mass spectrometry (LC-MS/MS) was
used to identify peptide sequences using a splitless nanoflow
EASY-nLC (Proxeon Biosystems, Odense, Denmark) with a self-
packed 75 mm-id615-cm C18 column coupled to a hybrid linear
ion trap LTQ Orbitrap XL mass spectrometer (Thermo Fisher
Scientific, San Jose, CA) in data-dependent acquisition and
positive ion mode at 300 nL/min. MS/MS spectra collected via
collision-induced dissociation (CID) were searched against the
concatenated target and decoy (reversed) Swiss-Prot protein
databases using Sequest [Proteomics Browser Software (PBS),
Thermo Fisher Scientific] with differential modifications for Met
oxidation (+15.99) and fixed modification for Cys alkylation
(+57.02). Protein groups were identified if they contained at least
two unique peptide sequences from the target database and a
TMSf
score .1. False discovery rate (FDR) was calculated to be .1%
based on reversed database hits. Single ungrouped sequences were
identified if they had Sf scores greater than 0.85 and passed the
1% FDR threshold. Proteins were semi-quantified between
experimental conditions using spectral counting and subtractive
analyses.
Cell Based Kinase Assays
HEK cells were transiently transfected with cDNA in the 6-well
format at 50% confluency. The next day, the cells were incubated
for 1 h in phosphate-free DMEM media (Invitrogen) after which
166 mCi of P
32 inorganic orthophosphate was added to each well.
The cells were lysed 2 h later for immunoprecipitation and
Western Blot analysis. 1 mg of pGLUE constructs, 100 ng of GFP
and GFP tagged kinases were transfected where stated.
Reporter Assays
HEK cells in 24-well plates were transfected with a master mix
of 10 ng of M34-luc, 5 ng of renilla, 25 ng of GFP. 25 ng of BMAL
and CLOCK and 3.3 pmols of siRNA were also transfected as
indicated. Cells were harvested 24 h later and assayed using
Promega’s Dual Luciferase Assay Kit.
Stealth human siRNAs were obtained from Invitrogen (please
contact corresponding author for sequence details if desired)
Control Medium GC #2: Forward/Reverse Cat no. 12935112
PHB2: Forward/Reverse Cat no. 10620318/9 PHB2HSS117604
&5
CK1d: Forward/Reverse Cat no. 10620318/9
CSNK1DHSS102382
CK1e: Forward/Reverse Cat no. 10620318/9
CSNK1EHSS102385
PER2: Forward/Reverse Cat no. 10620318/9
PER2HSS113092
STIP1: Forward/Reverse Cat no. 10620318/9
CSNK1EHSS102385
GNBL1L2: Forward/Reverse Cat no. 10620318/9
GNBL1L2HSS115921
SNX24: Forward/Reverse Cat no. 10620318/9
SNX24HSS120748
CRY2: Forward/Reverse Cat no. 10620318/9
CRY2HSS102310
CXORF39: Forward/Reverse Cat no. 10620318/9
CXORF39HSS151899
FAM83H: Forward/Reverse Cat no. 10620318/9
FAM83HHSS138850
IRS4: Forward/Reverse Cat no. 10620318/9 IRS4HSS112348
PHB1: Forward/Reverse Cat no. 1299003 PHB HSS182281 &
2&3
Lumicycle Assays
U2OS cells stably expressing luciferase driven by the BMAL1
promoter were transfected with siRNA prior to synchronization
and bioluminescence was then monitored over several days.
Dexamethasone was used to synchronize the cells 24 h after
transfection. Period lengths from Day 1 and 2 were determined in
plates with good oscillation using LumiCycle Analysis software.
RT-qPCR
Human. We quantified PER2, PHB2 and GAPDH (internal
control for normalization) transcripts from cells transfected with
control, PHB2, CK1d, CK1e and PER2 siRNAs. Total RNA was
isolated from HEK cells transfected with siRNA (6.6 pmol in a 24-
well plate format) using RNAeasy Mini Qiagen Kit. Reverse
CDNA was made using Invitrogen SuperScript III kit. Absolute
quantification was determined using PCR standards and carried
out with ABI Sybr Green/ROX with gene specific primers. Data
was collected and analyzed with ABI 7900HT machine and
software, respectively. GAPDH was used as an internal control.
Primer sequences:
PER2 Forward 59 GGAGAGCCGAAATTTGTAA 39
Reverse 59 CCAAGTACCTGATGACGCT 39
PHB2 Forward 59 GGCCCAGGTATCCCTGTT 39
Reverse 59 GGCCATCGTCTTGGAGATA 39
GAPDH Forward 59 CCACCCATGGCAAATTCCAT
39 Reverse 59 TCTAGACGGCAGGTCAGGTC 39
Drosophila. RNA was isolated by the same method described
above from 30–60 fly heads per genotype.
dphb1 Forward 59 GGCTGCTCAGTTCTTTAA 39
Reverse 59 CATCTCACGCT 39
dphb2 Forward 59 GCACACAGCAAATTGAA 39
Reverse 59 GGGATACCTGCTGACGCT 39
rpl32 Forward 59 GCTAAGCTGTCGCACAAAT 39
Reverse 59 CGCAGGCCGACCGTTGGGGTT 39
PHB2 protein modulation
SiRNA-facilitated KO of CK1d and CK1e mRNA was carried
out in HEK cells before PHB2 and ACTIN expression levels were
determined by immunoblotting followed by densitometry analysis.
CK1 Proteomics Reveal PHB2 as Clock Regulator
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Procedures were carried out as described in [3]. Wild-type flies
were w
118. RNAi lines were obtained from VDRC. RNAi lines for
dphb2 were line 32362 and 110070. Dphb1 lines used were 12358
and 12360. For overexpression, hphb2 was cloned into the
pUAST construct, injected into larva to make transgenic lines. Cry-
GAL4 lines were a kind gift from Allada lab.
Supporting Information
Figure S1 Gene oscillation and validation of binding/
knockdown of PHBs in HEK cells. (A) HEK293 cells can be
synchronized with dexamethasone. HEK cells at ,80% con-
fluency were treated with 100 nM dexamethasone for 2 h and
harvested 12, 16, 20, 24, 28, 32, 36, 40 and 44 h later. Per2 and
Cdk4 transcript levels were quantified using RTPCR. Per2
transcript levels were normalized to Cdk4. Per2 levels oscillate as
previously shown in [6]. (B) Western Blot showing that PHB and
PHB2 are binding partners. Cells were transfected with HA-
tagged PHB and GFP-tagged PHB2 and vice versa. HA tagged
proteins were purified using streptavidin beads. (C) Graph showing
knockdown efficiency relative to control siRNA of PHB1 and
PHB2 siRNA. Respective siRNAs were cotransfected transiently
with HA-PHB or HA-PHB2 and GFP to normalize for
transfection and expression into HEK cells. Lysates were analyzed
by Western Blot and densitometry was utilized to quantify band
intensity.
(TIF)
Figure S2 dPHBs are not circadianly-regulated genes
and RNAi knockdown efficiency. (A) RTPCR showing dphb
and dphb2 transcripts from fly heads in constant darkness. (B)
RTPCR results showing transcript levels of dphb in two phb RNAi
lines (phb1rnai1 and phb1rnai2) and two phb2 RNAi lines
(phb2rnai1 and phb2rnai2). (C) RTPCR results showing transcript
levels of dphb2 in two phb RNAi lines (phb1rnai1 and phb1rnai2)
and two phb2 RNAi lines (phb2rnai1 and phb2rnai2).
(TIF)
Figure S3 Adult locomotor activity actograms and chi-
squared periodograms (insets) of control flies (left) and
those expressing UAS-dphb2RNAi (middle) and UAS-dbt
(right). To test the role of PHB2 on circadian regulation in vivo,
we utilized RNAi expression to knock-down Drosophila PHB2
(dphb2, (CG15081)). Due to the essential role for dprohibitins in
early development, we drove expression only in cryptochrome(cry)-
expressing circadian neurons [16]. (A) UAS-DCRII;Cry16-GAL4
driven expression. When we monitored locomotor activity of adult
flies with one copy of UAS-Dicer II (UAS-DCRII) and Cry16-GAL4,
their period length was 25.4 h60.1 h (Fig. S3A, left and Table S2).
As has previously been shown [3], overexpressing double-time (dbt),
an orthologue of CK1 (NP_733414), results in a longer period
length (26.5 h60.2 h) (Fig. S3A, right). We found that RNAi
facilitated knock-down of dphb2 but not dphb1 led to period
arrhythmicity in a majority of flies tested (Fig. S3A middle, Table
S2). Dphb1 (Fig. S2B) and dphb2 (Fig. S2C) mRNA levels were
decreased following the expression of their respective RNAi. (B)
Cry39-GAL4 driven expression. Furthermore, knock-down of dphb2
using a Cry39-GAL4 driver (Table S2) resulted in flies exhibiting a
significantly longer period length (25.2 h60.2 h) compared to
control (24.4 h60.1 h, p,0.001). (C) RTPCR showing the
overexpression of human PHB and PHB2 in fly heads using
GAL4/UAS system. Since driving expression of a second available
phb2 RNAi line (UAS-dphb2RNAi2) did not lead to a decrease in
dphb2 mRNA (Fig. S2C) or show any phenotype (data not shown),
we chose to rescue the phenotype elicited in Cry39-GAL4/UAS-
dphb2RNAi flies by overexpressing human PHB2. Overexpressing
hPHB2 partially rescued the period length of Cry39-GAL4/UAS-
dphb2RNAi flies (Table S2).
(TIF)
Table S1 CK1d and CK1e proteomics Mass Spectrom-
etry results.
(XLS)
Table S2 PHB2 function in fly locomotor activity
assays. Adult fly locomotor activity results showing period
lengths and rhythmicity. Expression of human transcripts are
shown in Fig. S3C.
(XLSX)
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